SCHEMBL28455902

SCHEMBL28455902

CC(C)n1nc(-c2ccc3[nH]c(N)cc3c2)c2c(N)ncnc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 20/20 0.76
ABL1 P00519 19/20 0.76
HCK P08631 17/20 0.76
PIK3CD O00329 16/20 0.76
PIK3CA P42336 16/20 0.76
PIK3CB P42338 16/20 0.76
PIK3CG P48736 16/20 0.76
PRKDC P78527 16/20 0.76
EGFR P00533 16/20 0.76
KDR P35968 15/20 0.76
MTOR P42345 15/20 0.76
EPHB4 P54760 15/20 0.76
PI4KB Q9UBF8 5/20 0.73
LCK P06239 2/20 0.64
EPHA3 P29320 2/20 0.64
CSK P41240 2/20 0.64
BMPR1B O00238 1/20 0.64
PLK4 O00444 1/20 0.64
PIK3C2B O00750 1/20 0.64
CASK O14936 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24907281 0.91 KDR (0.73) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL2315798 0.84 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL29391405 0.81 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL14574867 0.81 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL18196381 0.81 SRC (0.80) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL2320180 0.80 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL2468132 0.80 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL12108174 0.79 SRC (0.79) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL14574574 0.79 SRC (0.80) SRCABL1HCKPIK3CDPIK3CA
SCHEMBL3613345 0.79 SRC (1.00) SRCABL1HCKPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107075482-B Treatment of cancer using anti-CD 19 chimeric antigen receptors 诺华股份有限公司 2021-03-16 CN disclosed
CN-112481283-A Treatment of cancer using CD33 chimeric antigen receptor 诺华股份有限公司 2021-03-12 CN disclosed
CN-112410363-A anti-CD 123 Chimeric Antigen Receptor (CAR) for cancer therapy 诺华股份有限公司 2021-02-26 CN disclosed
CN-107109419-B Treatment of cancer using CD33 chimeric antigen receptor 诺华股份有限公司 2020-12-22 CN disclosed
CN-107108744-B anti-CD 123 Chimeric Antigen Receptor (CAR) for cancer therapy 诺华股份有限公司 2020-09-25 CN disclosed
CN-111514283-A Treatment of cancer using anti-CD 19 chimeric antigen receptors 诺华股份有限公司 2020-08-11 CN disclosed